.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
US Department of Justice
UBS
AstraZeneca
Colorcon
Citi
Farmers Insurance
Healthtrust
Accenture

Generated: September 23, 2017

DrugPatentWatch Database Preview

ERLOTINIB HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Erlotinib Hydrochloride, and what generic Erlotinib Hydrochloride alternatives are available?

Erlotinib Hydrochloride is a drug marketed by Mylan Pharms Inc and Teva Pharms Usa and is included in two NDAs.

The generic ingredient in ERLOTINIB HYDROCHLORIDE is erlotinib hydrochloride. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the erlotinib hydrochloride profile page.

Summary for Tradename: ERLOTINIB HYDROCHLORIDE

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list72
Clinical Trials: see list2,859
Patent Applications: see list12
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERLOTINIB HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
ERLOTINIB HYDROCHLORIDE
erlotinib hydrochloride
TABLET;ORAL091002-001Jun 11, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ERLOTINIB HYDROCHLORIDE
erlotinib hydrochloride
TABLET;ORAL091059-002Aug 28, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ERLOTINIB HYDROCHLORIDE
erlotinib hydrochloride
TABLET;ORAL091002-002Jun 11, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ERLOTINIB HYDROCHLORIDE
erlotinib hydrochloride
TABLET;ORAL091002-003Jun 11, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ERLOTINIB HYDROCHLORIDE
erlotinib hydrochloride
TABLET;ORAL091059-003Aug 28, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Citi
Colorcon
AstraZeneca
Daiichi Sankyo
Cantor Fitzgerald
Healthtrust
Farmers Insurance
Covington
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot